ECSP972109A - STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST TUMORS - Google Patents

STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST TUMORS

Info

Publication number
ECSP972109A
ECSP972109A ECSP972109A ECSP972109A EC SP972109 A ECSP972109 A EC SP972109A EC SP972109 A ECSP972109 A EC SP972109A EC SP972109 A ECSP972109 A EC SP972109A
Authority
EC
Ecuador
Prior art keywords
guest
stimulation
defense mechanisms
against tumors
mechanisms against
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Michael Gerard Tovey
Thomas James Kaido
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972109 priority Critical patent/ECSP972109A/en
Publication of ECSP972109A publication Critical patent/ECSP972109A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición para tratar una enfermedad neoplástica en mamíferos y administrar al mamífero una cantidad terapéuticamente efectiva de un interferón vía contacto oromucosal. La cantidad de interferón administrado es menor que la cantidad que induce una respuesta patológica cuando es administrada parenteralmente.A composition for treating mammalian neoplastic disease and administering to the mammal a therapeutically effective amount of an interferon via oromucosal contact. The amount of interferon administered is less than the amount that induces a pathological response when administered parenterally.

ECSP972109 1997-05-08 1997-05-08 STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST TUMORS ECSP972109A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972109 ECSP972109A (en) 1997-05-08 1997-05-08 STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST TUMORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972109 ECSP972109A (en) 1997-05-08 1997-05-08 STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST TUMORS

Publications (1)

Publication Number Publication Date
ECSP972109A true ECSP972109A (en) 1998-07-23

Family

ID=42042940

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972109 ECSP972109A (en) 1997-05-08 1997-05-08 STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST TUMORS

Country Status (1)

Country Link
EC (1) ECSP972109A (en)

Similar Documents

Publication Publication Date Title
ATE316792T1 (en) STIMULATION OF THE HOST'S OWN DEFENSE MECHANISMS AGAINST CANCER
ES2187659T3 (en) TREATMENT OF TYPE II MELLITUS DIABETES WITH AMILINA AGONISTS.
DE69621012D1 (en) USE OF NSAIDS FOR THE TREATMENT OF squamous cell carcinoma of the oral cavity and throat
ES2162615T3 (en) METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION.
PT814796E (en) USE OF A PHARMACEUTICAL R-AINE IN A PROTEIN COMPOSITION FOR THE TREATMENT OF COLORECTAL CANCER
ES2190472T3 (en) TRANSDERMIC PATCH FOR THE ADMINISTRATION OF 17-DEACETIL NORGESTIMATO, ONLY OR IN COMBINATION WITH A STROGEN.
BR0111800A (en) Depeptidyl peptidase iv inhibitor combinations and other antidiabetic agents for the treatment of diabetes mellitus
EP0947222A3 (en) Method of activating photosensitive agents
PT850068E (en) LIPID EXTRACT WITH ANTI-INFLAMMATORY ACTIVITY
ES2144119T3 (en) USE OF NON-STEROID CYCLOOXYGENASE INHIBITORS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HIGH INTRAOCULAR PRESSURE.
CA2116559A1 (en) Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
ES2149776T3 (en) MODULATION, INDUCED BY A MORPHOGEN, OF THE INFLAMMATORY RESPONSE.
ATE180976T1 (en) INSIZABLE LECITHIN GEL
CA2289717A1 (en) Novel therapy for constipation
ES2068705T3 (en) TREATMENT OF NEOPLASTIC DISEASE WITH INTERLEUKIN-10.
PT1173201E (en) METHOD FOR THE TREATMENT OF FIBROSIS USING AN ALTAGONIST OF THE ALPHA 4 SUBSTANCE OF INTEGRINA
BR0211336A (en) Methods for the treatment of liver fibrosis
ES2133289T3 (en) INCREASE IN GLUTATION LEVELS WITH GLUTAMINE.
BR9810445A (en) Diabetes treatment with thiazolidinedione, insulin secretagogue and diguanide
CO4960654A1 (en) METHOD FOR THE TREATMENT OF PHYSIOLOGICAL DISEASES RELATED TO THE USE OR SEQUELS CAUSED BY THE USE OF COCAINE OR OTHER PSYCHOMOTOR STIMULANTS
KR910009267A (en) How to Treat Depression
AR007059A1 (en) USE OF INTERFERON IN THE PREPARATION OF MEDICINES AND COMPOSITIONS VIA OROMUCOSAL OR BY CONTACT
ECSP972107A (en) STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST VIRAL STIMULATIONS
BR9915214A (en) Combinations containing a beta-agonist and an additional anti-diabetic agent
BR9106166A (en) USE OF CETOROLAC FOR THE TREATMENT OF PERIODONTAL DISEASE